Literature DB >> 24828264

Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI.

Zhe Zhang1, Haihui Jiang, Xuzhu Chen, Jiwei Bai, Yong Cui, Xiaohui Ren, Xiaolin Chen, Junmei Wang, Wei Zeng, Song Lin.   

Abstract

This study was to project a powerful volumetric-related parameter on magnetic resonance imaging (MRI) for classifying patients with glioblastoma multiforme (GBM) into distinct subgroups objectively. The preoperative MRIs of 147 patients with primary GBM were analyzed. Volumetric-related parameters, including V1 (tumor volume), V2 (peritumoral T2/FLAIR hyperintense volume) and V2/V1 (the volume ratio), were estimated by an ellipsoid model. Log-rank analysis and Cox regression methods were used to compare Kaplan-Meier plots and identified prognostic parameters. Log-rank analysis revealed that V1 and V2 were correlated with survival, but the P value was marginally significant (P = 0.082, P = 0.091, for progression-free survival [PFS]; P = 0.120, P = 0.073, for overall survival [OS], respectively). V2/V1 was a potential prognostic factor for both PFS and OS (P < 0.001 and P < 0.001, respectively). Cox regression analysis documented that higher V2/V1 (ratio ≥ 7.0) was independent unfavorable prognostic factor. The odd ratio (OR) of higher V2/V1 was 2.662 (95 % confidence interval [CI], 1.782-3.975; P < 0.001) for PFS and 3.450 (95 % CI, 2.079-5.725; P < 0.001) for OS, respectively. The volumetric-related parameters of V1, V2 and V2/V1 were helpful for predicting the prognosis of patients with GBM. V2/V1 was a more comprehensive and systematic prognostic factor in GBM patient, especially for those with small tumor but large peritumoral T2 hyperintense or large tumor but small peritumoral T2 hyperintense.

Entities:  

Mesh:

Year:  2014        PMID: 24828264     DOI: 10.1007/s11060-014-1478-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Authors:  John K Park; Tiffany Hodges; Leopold Arko; Michael Shen; Donna Dello Iacono; Adrian McNabb; Nancy Olsen Bailey; Teri Nguyen Kreisl; Fabio M Iwamoto; Joohee Sul; Sungyoung Auh; Grace E Park; Howard A Fine; Peter McL Black
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.

Authors:  F Earnest; P J Kelly; B W Scheithauer; B A Kall; T L Cascino; R L Ehman; G S Forbes; P L Axley
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

4.  Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2.

Authors:  Marc R J Carlson; Whitney B Pope; Steve Horvath; Jerome G Braunstein; Phioanh Nghiemphu; Cho-Lea Tso; Ingo Mellinghoff; Albert Lai; Linda M Liau; Paul S Mischel; Jun Dong; Stanley F Nelson; Timothy F Cloughesy
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

5.  Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.

Authors:  Kourosh M Naeini; Whitney B Pope; Timothy F Cloughesy; Robert J Harris; Albert Lai; Ascia Eskin; Reshmi Chowdhury; Heidi S Phillips; Phioanh L Nghiemphu; Yalda Behbahanian; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2013-02-26       Impact factor: 12.300

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

7.  The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.

Authors:  Georgios Iliadis; Panagiotis Selviaridis; Anna Kalogera-Fountzila; Anna Fragkoulidi; Dimos Baltas; Nikolaos Tselis; Athanasios Chatzisotiriou; Despina Misailidou; Nikolaos Zamboglou; George Fountzilas
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

8.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Authors:  Kaisorn Chaichana; Scott Parker; Alessandro Olivi; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

9.  Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.

Authors:  Daniela Lötsch; Bahil Ghanim; Magdalena Laaber; Gabriele Wurm; Serge Weis; Stefan Lenz; Gerald Webersinke; Josef Pichler; Walter Berger; Sabine Spiegl-Kreinecker
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

10.  Volumetric and MGMT parameters in glioblastoma patients: survival analysis.

Authors:  Georgios Iliadis; Vassiliki Kotoula; Athanasios Chatzisotiriou; Despina Televantou; Anastasia G Eleftheraki; Sofia Lambaki; Despina Misailidou; Panagiotis Selviaridis; George Fountzilas
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

View more
  16 in total

1.  Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.

Authors:  Guido H Jajamovich; Chandni R Valiathan; Razvan Cristescu; Sangeetha Somayajula
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

2.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.

Authors:  Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

3.  Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.

Authors:  Julián Pérez-Beteta; Alicia Martínez-González; David Molina; Mariano Amo-Salas; Belén Luque; Elena Arregui; Manuel Calvo; José M Borrás; Carlos López; Marta Claramonte; Juan A Barcia; Lidia Iglesias; Josué Avecillas; David Albillo; Miguel Navarro; José M Villanueva; Juan C Paniagua; Juan Martino; Carlos Velásquez; Beatriz Asenjo; Manuel Benavides; Ismael Herruzo; María Del Carmen Delgado; Ana Del Valle; Anthony Falkov; Philippe Schucht; Estanislao Arana; Luis Pérez-Romasanta; Víctor M Pérez-García
Journal:  Eur Radiol       Date:  2016-06-21       Impact factor: 5.315

4.  Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Authors:  Cecelia Elizabeth Gzell; Helen R Wheeler; Philip McCloud; Marina Kastelan; Michael Back
Journal:  J Neurooncol       Date:  2016-02-15       Impact factor: 4.130

5.  Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Authors:  Prateek Prasanna; Jay Patel; Sasan Partovi; Anant Madabhushi; Pallavi Tiwari
Journal:  Eur Radiol       Date:  2016-10-24       Impact factor: 5.315

6.  Effects of anti-angiogenesis on glioblastoma growth and migration: model to clinical predictions.

Authors:  Elizabeth Scribner; Olivier Saut; Paula Province; Asim Bag; Thierry Colin; Hassan M Fathallah-Shaykh
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

7.  Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.

Authors:  Niha Beig; Jay Patel; Prateek Prasanna; Virginia Hill; Amit Gupta; Ramon Correa; Kaustav Bera; Salendra Singh; Sasan Partovi; Vinay Varadan; Manmeet Ahluwalia; Anant Madabhushi; Pallavi Tiwari
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

8.  Efficacy of Location-Based Features for Survival Prediction of Patients With Glioblastoma Depending on Resection Status.

Authors:  Madjid Soltani; Armin Bonakdar; Nastaran Shakourifar; Reza Babaie; Kaamran Raahemifar
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

9.  Somatic mutations associated with MRI-derived volumetric features in glioblastoma.

Authors:  David A Gutman; William D Dunn; Patrick Grossmann; Lee A D Cooper; Chad A Holder; Keith L Ligon; Brian M Alexander; Hugo J W L Aerts
Journal:  Neuroradiology       Date:  2015-09-04       Impact factor: 2.804

10.  Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features.

Authors:  Emmanuel Rios Velazquez; Raphael Meier; William D Dunn; Brian Alexander; Roland Wiest; Stefan Bauer; David A Gutman; Mauricio Reyes; Hugo J W L Aerts
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.